Bingshu E. Chen

Treatment outcomes for older patients with relapsed/refractory aggressive lymphoma receiving salvage chemotherapy and autologous stem cell transplantation are similar to younger patients: a subgroup analysis from the phase III CCTG LY.12 trial

K. Davison, V. Kukreti, M. Crump, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Gemcitabine/dexamethasone/cisplatin vs cytarabine/dexamethasone/cisplatin for relapsed or refractory aggressive-histology lymphoma: cost-utility analysis of NCIC CTG LY.12.

Bingshu E. Chen, V. Kukreti, M. Crump, 2015, Journal of the National Cancer Institute.

a case report and literature review of primary resistant Hodgkin lymphoma: a response to anti-pD-1 after failure of autologous stem cell transplantation and brentuximab vedotin

Xiao-yan Shao, Chao-yang Guan, Fan Wang, 2016 .

The economic impact of the transition from branded to generic oncology drugs.

D. Tu, R. Ng, E. A. Kornelsen, 2019, Current Oncology.